Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « number »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
nucleotides < number < numbers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000007 (2020) Danièle Allali ; Marc Blondon ; Pascale Roux-Lombard ; David Spoerl[How to manage giant cell arteritis].
000048 (2020) Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000059 (2020) Banafsheh Mosharmovahed [Iran] ; Yousef Fatahi [Iran] ; Bahareh Mohebbi [Iran] ; Sohrab Ali Ghorbanian [Iran] ; Sara Assadiasl [Iran]Tocilizumab in transplantation.
000080 (2020) Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria GasperiThe “Janus Face” of Platelets in Cancer
000103 (2020) Champa N. Ratnatunga [Australie] ; Viviana P. Lutzky [Australie] ; Andreas Kupz [Australie] ; Denise L. Doolan [Australie] ; David W. Reid [Australie] ; Matthew Field [Australie] ; Scott C. Bell [Australie] ; Rachel M. Thomson [Australie] ; John J. Miles [Australie]The Rise of Non-Tuberculosis Mycobacterial Lung Disease
000114 (2020) Pia M. Vidal [Chili] ; Rodrigo Pacheco [Chili]The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
000116 (2020) Xi-Ying Wang [République populaire de Chine] ; Fen Zhang [République populaire de Chine] ; Chi Zhang [République populaire de Chine] ; Liang-Rong Zheng [République populaire de Chine] ; Jian Yang [République populaire de Chine]The Biomarkers for Acute Myocardial Infarction and Heart Failure
000160 (2020) Anna A. Starshinova [Russie] ; Anna M. Malkova [Russie] ; Natalia Y. Basantsova [Russie] ; Yulia S. Zinchenko [Russie] ; Igor V. Kudryavtsev [Russie] ; Gennadiy A. Ershov [Russie] ; Lidia A. Soprun [Russie] ; Vera A. Mayevskaya [Russie] ; Leonid P. Churilov [Russie] ; Piotr K. Yablonskiy [Russie]Sarcoidosis as an Autoimmune Disease
000161 (2020) Shiyuan Wen [République populaire de Chine] ; Feng Wang [République populaire de Chine] ; Zhenhua Ji [République populaire de Chine] ; Yingyi Pan [République populaire de Chine] ; Miaomiao Jian [République populaire de Chine] ; Yunfeng Bi [République populaire de Chine] ; Guozhong Zhou [République populaire de Chine] ; Lisha Luo [République populaire de Chine] ; Taigui Chen [République populaire de Chine] ; Lianbao Li [République populaire de Chine] ; Zhe Ding [République populaire de Chine] ; Manzama-Esso Abi [République populaire de Chine] ; Aihua Liu [République populaire de Chine] ; Fukai Bao [République populaire de Chine]Salp15, a Multifunctional Protein From Tick Saliva With Potential Pharmaceutical Effects
000169 (2020) Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie]Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.
000177 (2020) Kaveh Hajifathalian ; Srihari Mahadev ; Robert E. Schwartz ; Shawn Shah ; Kartik Sampath ; Felice Schnoll-Sussman ; Robert S. Brown Jr ; David Carr-Locke ; David E. Cohen ; Reem Z. SharaihaSARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000237 (2020) Zaid H. Temrikar [États-Unis] ; Satyendra Suryawanshi [États-Unis] ; Bernd Meibohm [États-Unis]Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
000240 (2020) James Kalmuk [États-Unis] ; Jon Puchalla [États-Unis] ; Gong Feng [États-Unis] ; Anshu Giri [États-Unis] ; John Kaczmar [États-Unis]Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
000268 (2020) Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine]NK Cell-Based Immune Checkpoint Inhibition
000320 (2020) Rachel A. O Eefe ; Neil E. Bhola ; David S. Lee ; Daniel E. Johnson ; Jennifer R. GrandisInterleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
000338 (2020) Ivan Arias De La Rosa [Espagne] ; Carlos Perez-Sanchez [Royaume-Uni] ; Patricia Ruiz-Limon [Espagne] ; Alejandra Pati O-Trives [Espagne] ; Carmen Torres-Granados [Espagne] ; Yolanda Jimenez-Gomez [Espagne] ; Maria Del Carmen Abalos-Aguilera [Espagne] ; Irene Cecchi [Italie] ; Rafaela Ortega [Espagne] ; Miguel Angel Caracuel [Espagne] ; Jerusalem Calvo-Gutierrez [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Chary Lopez-Pedrera [Espagne] ; Nuria Barbarroja [Oman]Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000356 (2020) Catharine Morgan ; Ruth E. Costello ; David W. Ray ; William G. DixonHow Do Glucocorticoids Used in Rheumatic Disease Affect Body Weight? A Narrative Review of the Evidence
000359 (2020) Yanyan Han ; Takuro Igawa ; Kyohei Ogino ; Asami Nishikori ; Yuka Gion ; Tadashi Yoshino ; Yasuharu SatoHemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "number" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "number" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    number
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021